Evidence map›Paper›PMID 36840018›Full record

ReviewPharmaceutics2023

Drug Delivery Systems in Regenerative Medicine: An Updated Review.

Alaa Mansour, Maya Romani, Anirudh Balakrishna Acharya, Betul Rahman, Elise Verron, Zahi Badran

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Alaa MansourPeriodontology Unit, College of Dental Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.ORCID 0000-0001-5950-4092
Maya RomaniDepartment of Family Medicine, Faculty of Medicine, American University of Beirut, Beirut 1107, Lebanon.
Anirudh Balakrishna AcharyaPeriodontology Unit, College of Dental Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.
Betul RahmanPeriodontology Unit, College of Dental Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.
Elise VerronCNRS, CEISAM, UMR 6230, Nantes Université, F-44000 Nantes, France.ORCID 0000-0003-4276-5127
Zahi BadranPeriodontology Unit, College of Dental Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.ORCID 0000-0003-2592-4333
University of Sharjah · AEAmerican University of Beirut · LBCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modern drug discovery methods led to evolving new agents with significant therapeutic potential. However, their properties, such as solubility and administration-related challenges, may hinder their benefits. Moreover, advances in biotechnology resulted in the development of a new generation of molecules with a short half-life that necessitates frequent administration. In this context, controlled release systems are required to enhance treatment efficacy and improve patient compliance. Innovative drug delivery systems are promising tools that protect therapeutic proteins and peptides against proteolytic degradation where controlled delivery is achievable. The present review provides an overview of different approaches used for drug delivery.

Indexed as

drug deliverynanoparticlesregeneration

Identifiers

PMID36840018
PMCPMC9967372
OpenAlexW4321373043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.